Tanya Knott
Founder SJK Foundation
IRELAND
Dr Natalie Cook
Clinical Snr Lecturer Exp Cancer Med
The Christie NHS Foundation Trust
UK
Prof. Alwin Kramer
Head of division molecular hematology/oncology
German Cancer Research Center Heidelberg
GERMANY
Prof. Linda Mileshkin
Deputy director Medical Oncology
Peter MacCallum Cancer Centre, Victoria
AUSTRALIA
Warnyta Minnaard
Co-founder Missie Tumor Onbekend
NETHERLANDS
Kanwal Raghav
USA
A/Prof. Richard Tothill
Associate Professor at University of Melbourne
AUSTRALIA
Alison Taylor
Cancer of Unknown Primary (CUP) Nurse Consultant at The Clatterbridge Cancer Centre
UK
Petur Snaebjornsson
Professor of pathology with special interest
in cancer of unknown primary (CUP)
NETHERLANDS
Tanya Knott
Founder SJK Foundation
IRELAND
Dr Natalie Cook
Clinical Snr Lecturer Exp Cancer Med
The Christie NHS Foundation Trust
UK
Prof. Alwin Kramer
Head of division molecular hematology/oncology
German Cancer Research Center Heidelberg
GERMANY
Prof. Linda Mileshkin
Deputy director Medical Oncology
Peter MacCallum Cancer Centre, Victoria
AUSTRALIA
Warnyta Minnaard
Co-founder Missie Tumor Onbekend
NETHERLANDS
Kanwal Raghav
USA
A/Prof. Richard Tothill
Associate Professor at University of Melbourne
AUSTRALIA
Alison Taylor
Cancer of Unknown Primary (CUP) Nurse Consultant at The Clatterbridge Cancer Centre
UK
Petur Snaebjornsson
Professor of pathology with special interest
in cancer of unknown primary (CUP)
NETHERLANDS
About WCA
After having organized two World CUP Awareness Weeks in 2021 and 2022 with awareness events and informative webinars for patients and clinicians, reaching 9 million accounts in 170 countries, SJK Foundation (Ireland) and Missie Tumor Onbekend (the Netherlands) have joined forces to launch the first international Cancer of Unknown Primary (CUP) patient advocacy alliance.
It is our objective to build an international alliance of all those patient advocates that are focused on improving diagnostics, treatments and care journeys for all patients affected by CUP. Together we are advocates for the implementation of, awareness of and accessibility of precision oncology. As innovations in oncology and the ease of patient interaction is truly happening on a global scale, it is now more important than ever, to share knowledge and learn from examples in different countries and across health systems.
To date we have been able to unite patient advocates not only from Ireland and the Netherlands, but also including the UK, the US and Belgium. The World CUP Alliance will pursue three main activities.
Raise awareness and provide information
& peer support to patients
Support the development of universal patient information folders in different languages on the basis of best practices and tailored to national settings
Continue to organize (bi)-yearly World CUP Awareness Weeks to increase awareness and focus attention on unmet needs
Support the organization of “Into the unknown” awareness and fundraising events in different countries
Raise awareness and provide information
& peer support to patients
Support the development of universal patient information folders in different languages on the basis of best practices and tailored to national settings
Continue to organize (bi)-yearly World CUP Awareness Weeks to increase awareness and focus attention on unmet needs
Support the organization of “Into the unknown” awareness and fundraising events in different countries
Advocating for the best CUP patient journey
Advocate for access to precision diagnostics & precision therapies, for example via patient journey mapping and sharing of relevant patient stories
Advocate for a ‘two-step approach’ in clinical care: the best diagnostics whilst at the same time offering best supportive care based on patient needs and preferences
Learn from and unite different national & international guidelines
Advocating for the best CUP patient journey
Advocate for access to precision diagnostics & precision therapies, for example via patient journey mapping and sharing of relevant patient stories
Advocate for a ‘two-step approach’ in clinical care: the best diagnostics whilst at the same time offering best supportive care based on patient needs and preferences
Learn from and unite different national & international guidelines
Co-establish & support international
research partnerships
Disseminate trial information and share best practices with patients and healthcare professionals
Provide an up-to-date overview of ongoing CUP clinical trials
Actively collaborate with research groups interested in multi-country CUP trials
Co-establish & support international
research partnerships
Disseminate trial information and share best practices with patients and healthcare professionals
Provide an up-to-date overview of ongoing CUP clinical trials
Actively collaborate with research groups interested in multi-country CUP trials
Tanya Knott
Founder
Tanya Knott has worked in the healthcare industry for over 25 years. A King’s College London and Trinity College Dublin graduate, Tanya has worked as a registered general nurse specialising in cardiothoracic, intensive care and emergency nursing. Tanya also has years of experience in market access in the pharmaceutical industry. When Sarah was diagnosed with Cancer of Unknown Primary (2015), Tanya realised there was a huge gap in knowledge and research in this disease area and set up the foundation with the aim of promoting improved awareness, research and education into Cancer of Unknown Primary (CUP). Tanya is also the co-founder of the WCA, World CUP Alliance (Cancer of Unknown Primary) www.worldcupalliance.org
Working together with global experts, patients, health care professionals, researchers and industry to promote education, awareness and research into CUP. The WCA are proud members of WECAN (Working European Cancer Advocacy Network) Tanya has written published articles and a white paper on the ‘Unmet needs of patients with Cancer of Unknown Primary” and has presented at many international conferences. Tanya is a former board member of ‘From Testing to Targeted Treatments’. FT3 is a global initiative to help ensure access to precision medicine for all patients who need it www.fromtestingtotargetedtreatments.org; she is also a member of the PPI and the national molecular tumour board steering committee at Cancer Trials Ireland.
Warnyta Minnaard
Founder
Warnyta Minnaard (1989) is one of the founders of ‘Missie Tumor Onbekend’, the Dutch advocacy organisation dedicated to improving care & survival for Cancer of Unknown Primary (CUP) patients. After her partner Hederik passed away in early 2019 amidst an ongoing diagnostic trajectory with leptomenigial metastases from a CUP; Warnyta started on a mission to change the situation for future patients. Together with another grieving family of a young CUP patient, they started the advocacy organisation. It’s her personal mission to expedite access to better personalised (molecular) diagnostics, improve knowledge and awareness of CUP, and enhance the care pathways and support opportunities for patients and their families. One of the biggest milestones to date has been Missie Tumor Onbekend pivotal role in obtaining Dutch Parliamentary approval in 2021 so that Whole Genome Sequencing became part of the insured diagnostic routine work-up for CUP patients in the Netherlands. Ever since 8 specialised CUP clinics have opened across the country.
Sara Santarelli
Brand & Comms
Sara Santarelli is an Italian architect and visual designer, living in Ireland. She’s the founder and head designer of SNDE VISUAL Design & Communication. Expert in branding and communication strategy, Sara has been working alongside Tanya since the set up of the Sarah Jennifer Knott Foundation in 2016. Leading the comms team (publications, web design, social media), Sara has been involved in various projects with the foundation ever since, including World CUP Awareness Week 2021 & 2022. She’s been part of the core team of the World CUP Alliance (Cancer of Unknown Primary) since its foundation and recently graduated from the Wecan Academy (Working European Cancer Advocacy Network).
Register here for updates
Missie Tumor Onbekend
Fannius Scholtenstraat 69,
1051EV, Amsterdam,
The Netherlands
Sarah Jennifer Knott Foundation,
38 Belgrave Road,
Rathmines,
D06 HW222,
Republic of Ireland
All Rights Reserved | Web Design by SNDE VISUAL Design & DIADEMADISARA